These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 36482288)
1. Reduced Klotho expression and its prognostic significance in canine hepatocellular carcinoma. Kim G; Chung H; Lee S; Kim WH Vet Comp Oncol; 2023 Mar; 21(1):91-99. PubMed ID: 36482288 [TBL] [Abstract][Full Text] [Related]
2. Aberrantly Expressed tRNA-Val Fragments Can Distinguish Canine Hepatocellular Carcinoma from Canine Hepatocellular Adenoma. Hashimoto S; Hasan MDN; Arif M; Nozaki N; Husna AA; Furusawa Y; Sogawa T; Takahashi K; Kuramoto T; Noguchi A; Takahashi M; Yamato O; Rahman MM; Miura N Genes (Basel); 2024 Aug; 15(8):. PubMed ID: 39202384 [TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of microRNAs and the miR-1/MET pathway in canine hepatocellular carcinoma. Lai YC; Ushio N; Rahman MM; Katanoda Y; Ogihara K; Naya Y; Moriyama A; Iwanaga T; Saitoh Y; Sogawa T; Sunaga T; Momoi Y; Izumi H; Miyoshi N; Endo Y; Fujiki M; Kawaguchi H; Miura N Vet Comp Oncol; 2018 Jun; 16(2):288-296. PubMed ID: 29314614 [TBL] [Abstract][Full Text] [Related]
4. Down-expression of klotho in canine mammary gland tumors and its prognostic significance. Chung H; Lee S; Kim GA; Kim WH PLoS One; 2022; 17(6):e0265248. PubMed ID: 35666743 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and Prognostic Significance of Klotho and Estrogen Receptors Expression in Human Hepatocellular Carcinoma. Huang S; Wang W; Cheng Y; Lin J; Wang M Turk J Gastroenterol; 2021 Oct; 32(10):828-836. PubMed ID: 34787087 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients. Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282 [TBL] [Abstract][Full Text] [Related]
7. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related]
8. Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker. Lui KY; Zhao H; Qiu C; Li C; Zhang Z; Peng H; Fu R; Chen HA; Lu MQ BMC Cancer; 2017 Sep; 17(1):644. PubMed ID: 28899352 [TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma. Lyu Z; Ma M; Xu Y; Wang X; Zhu Y; Ren W; Li T Int J Clin Oncol; 2020 Jul; 25(7):1334-1345. PubMed ID: 32347431 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of Klotho expression correlates with poor prognosis of human hepatocellular carcinoma. Xie B; Zhou J; Yuan L; Ren F; Liu DC; Li Q; Shu G Hum Pathol; 2013 May; 44(5):795-801. PubMed ID: 23123137 [TBL] [Abstract][Full Text] [Related]
11. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879 [TBL] [Abstract][Full Text] [Related]
12. High expression of Golgi phosphoprotein-3 is associated with poor survival in patients with hepatocellular carcinoma. Hu GS; Li YQ; Yang YM; Shi W; Liao AJ; Yao YH; Zeng B; Yuan J Tumour Biol; 2014 Sep; 35(9):8625-32. PubMed ID: 24867097 [TBL] [Abstract][Full Text] [Related]
13. High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma. Li M; Luo RZ; Chen JW; Cao Y; Lu JB; He JH; Wu QL; Cai MY J Transl Med; 2011 Jan; 9():5. PubMed ID: 21205329 [TBL] [Abstract][Full Text] [Related]
14. Restoration of klotho expression induces apoptosis and autophagy in hepatocellular carcinoma cells. Shu G; Xie B; Ren F; Liu DC; Zhou J; Li Q; Chen J; Yuan L; Zhou J Cell Oncol (Dordr); 2013 Apr; 36(2):121-9. PubMed ID: 23248036 [TBL] [Abstract][Full Text] [Related]
15. TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis. Wang XJ; Li FF; Zhang YJ; Jiang M; Ren WH Cancer Biomark; 2020; 29(3):307-315. PubMed ID: 32716348 [TBL] [Abstract][Full Text] [Related]
16. Overactivation of Signal Transducer and Activator of Transcription 3 in Canine Hepatocellular Carcinoma and Its Prognostic Significance. Shin HK; Chung HJ; Kim WH Vet Comp Oncol; 2024 Dec; 22(4):490-499. PubMed ID: 39135335 [TBL] [Abstract][Full Text] [Related]
17. Expression of Kindlin-1 in human hepatocellular carcinoma and its prognostic significance. Ma HX; Shu QH; Pan JJ; Liu D; Xu GL; Li JS; Ma JL; Jia WD; Yv JH; Ge YS Tumour Biol; 2015 Jun; 36(6):4235-41. PubMed ID: 25592379 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma. Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005 [No Abstract] [Full Text] [Related]
19. Identification and validation of EPHX2 as a prognostic biomarker in hepatocellular carcinoma. Zhan K; Bai Y; Liao S; Chen H; Kuang L; Luo Q; Lv L; Qiu L; Mei Z Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278494 [TBL] [Abstract][Full Text] [Related]
20. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]